Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報

【英語タイトル】Applied Genetic Technologies Corp (AGTC) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C12098)・商品コード:DATA904C12098
・発行会社(調査会社):GlobalData
・発行日:2018年12月
・ページ数:36
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pigmentosa, alpha-1 antitrypsin deficiency and macular degeneration, among others. AGTC’s achromatopsia provides treatment inherited conditions that are associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and total loss of color discrimination. The company’s x-linked retinoschisis offers treatment in retinal degeneration affecting young males, presenting with poor vision by school age. It also offers ophthalmology development programs and proof-of-concept data in multiple indications. The company operates through its offices in Alachua and Cambridge, the US, and others. AGTC is headquartered in Alachua, Florida, the US.

Applied Genetic Technologies Corp (AGTC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Applied Genetic Technologies Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Applied Genetic Technologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Applied Genetic Technologies Corp, Medical Equipment, Deal Details 10
Partnerships 10
Applied Genetic Tech Enters into R&D Agreement with Bionic Sight 10
Equity Offering 11
Applied Genetic Tech Plans to Raise up to USD125 Million in Public Offering of Securities 11
Acquisition 13
Applied Genetic Acquires 5% Stake in Bionic Sight for USD2 Million 13
Applied Genetic Technologies Corp – Key Competitors 14
Applied Genetic Technologies Corp – Key Employees 15
Applied Genetic Technologies Corp – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
Sep 10, 2018: AGTC announces financial results and business update for the fourth quarter and fiscal year ended June 30, 2018 17
May 08, 2018: AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2018 19
Feb 09, 2018: AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017 21
Sep 13, 2017: AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2017 23
May 10, 2017: AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2017 25
Feb 08, 2017: AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2016 28
Corporate Communications 30
Sep 24, 2018: AGTC names William Aliski to its board of directors 30
Jun 14, 2018: AGTC Announces Expansion of Clinical and Regulatory Leadership Teams 31
Feb 14, 2018: AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization’s Board of Directors 32
Sep 05, 2017: AGTC Appoints Matthew Feinsod, M.D. as Interim Chief Medical Officer 33
Aug 02, 2017: AGTC Appoints William Sullivan as Chief Financial Officer, Andrew Ashe Named General Counsel 34
Product News 35
Aug 08, 2017: AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 16, 2017 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Applied Genetic Technologies Corp, Medical Equipment, Key Facts, 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Applied Genetic Technologies Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Deals By Market, 2012 to YTD 2018 8
Applied Genetic Technologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Applied Genetic Tech Enters into R&D Agreement with Bionic Sight 10
Applied Genetic Tech Plans to Raise up to USD125 Million in Public Offering of Securities 11
Applied Genetic Acquires 5% Stake in Bionic Sight for USD2 Million 13
Applied Genetic Technologies Corp, Key Competitors 14
Applied Genetic Technologies Corp, Key Employees 15

List of Figures
Applied Genetic Technologies Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Applied Genetic Technologies Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★調査レポート[Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C12098)販売に関する免責事項を必ずご確認ください。
★調査レポート[Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆